CEMENTIC

About CEMENTIC

Cementic develops lipid nanoparticles for dental disinfection and bone regeneration, specifically targeting bacterial infections in root canals and enhancing healing in orthopedic applications. Their bioceramic sealer releases antiseptic molecules at the nanoscale to eliminate pathogens, addressing complications that affect up to 60% of root canal patients.

```xml <problem> Bacterial infections following root canal procedures and bone grafting often lead to complications, including chronic pain, tissue damage, and impaired healing, affecting a significant percentage of patients. Current treatments may not fully eradicate pathogens at the nanoscale, hindering optimal recovery and long-term success. </problem> <solution> Cementic develops lipid nanoparticle-based solutions for dental disinfection and bone regeneration, targeting bacterial infections at the nanoscale. Their bioceramic sealer releases antiseptic molecules directly into root canals, eliminating pathogens and promoting healing. For bone regeneration, Cementic's technology focuses on immunomodulation to enhance bone growth in periodontics, oral surgery, and orthopedics. This versatile technology aims to improve patient outcomes by addressing the root causes of infection and promoting tissue regeneration. </solution> <features> - Bioceramic sealer with nanoscale antiseptic molecule release for root canal disinfection - Immunomodulatory lipid nanoparticles to improve bone regeneration - Targeted delivery of therapeutics to infected sites - Broad applicability across dental, orthopedic, and surgical applications </features> <target_audience> The primary target audience includes dentists, oral surgeons, periodontists, and orthopedic surgeons seeking advanced solutions for infection control and tissue regeneration. </target_audience> ```

What does CEMENTIC do?

Cementic develops lipid nanoparticles for dental disinfection and bone regeneration, specifically targeting bacterial infections in root canals and enhancing healing in orthopedic applications. Their bioceramic sealer releases antiseptic molecules at the nanoscale to eliminate pathogens, addressing complications that affect up to 60% of root canal patients.

Where is CEMENTIC located?

CEMENTIC is based in Palo Alto, United States.

When was CEMENTIC founded?

CEMENTIC was founded in 2016.

Location
Palo Alto, United States
Founded
2016
Employees
3 employees

CEMENTIC

2
Relative Traction Score based on online presence metrics compared to companies in the same age group.

Executive Summary

Cementic develops lipid nanoparticles for dental disinfection and bone regeneration, specifically targeting bacterial infections in root canals and enhancing healing in orthopedic applications. Their bioceramic sealer releases antiseptic molecules at the nanoscale to eliminate pathogens, addressing complications that affect up to 60% of root canal patients.

cementic.com100+
Founded 2016Palo Alto, United States

Funding

No funding information available.

Team (<5)

No team information available.

Company Description

Problem

Bacterial infections following root canal procedures and bone grafting often lead to complications, including chronic pain, tissue damage, and impaired healing, affecting a significant percentage of patients. Current treatments may not fully eradicate pathogens at the nanoscale, hindering optimal recovery and long-term success.

Solution

Cementic develops lipid nanoparticle-based solutions for dental disinfection and bone regeneration, targeting bacterial infections at the nanoscale. Their bioceramic sealer releases antiseptic molecules directly into root canals, eliminating pathogens and promoting healing. For bone regeneration, Cementic's technology focuses on immunomodulation to enhance bone growth in periodontics, oral surgery, and orthopedics. This versatile technology aims to improve patient outcomes by addressing the root causes of infection and promoting tissue regeneration.

Features

Bioceramic sealer with nanoscale antiseptic molecule release for root canal disinfection

Immunomodulatory lipid nanoparticles to improve bone regeneration

Targeted delivery of therapeutics to infected sites

Broad applicability across dental, orthopedic, and surgical applications

Target Audience

The primary target audience includes dentists, oral surgeons, periodontists, and orthopedic surgeons seeking advanced solutions for infection control and tissue regeneration.

Sources:

This profile is AI-generated from web data and may contain inaccuracies. Want to correct or remove an entry? Owners can claim edits via their company email domain, and signed-in users can submit sourced suggestions.
CEMENTIC | StartupSeeker